STOCK TITAN

Pulse Biosciences, Inc - $PLSE STOCK NEWS

Welcome to our dedicated page for Pulse Biosciences news (Ticker: $PLSE), a resource for investors and traders seeking the latest updates and insights on Pulse Biosciences stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pulse Biosciences's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pulse Biosciences's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.89%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.11%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.5%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.76%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.88%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.23%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.08%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.98%
Tags
none
Pulse Biosciences, Inc

Nasdaq:PLSE

PLSE Rankings

PLSE Stock Data

431.86M
16.31M
70.38%
8.07%
4.76%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
HAYWARD

About PLSE

pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and